Search

everythinglearnresearchcommunity

for

Search:↓

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Finasteride may help some women with hair loss, but better options exist.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.